Vaccination is a fast-moving field, with new vaccines and technologies being developed all the time. This year, 2024, is also a big one in Europe as elections to the European Parliament take place and a new European Commission takes office.
What do these technological and policy trends mean for the future of vaccination? This is one of the questions we’ll tackle in a free webinar on 16 January at 11:30am (CET).
Join us to hear from officials from the European Commission, European Cancer Organization, the Coalition for Life-Course Immunisation, as well as experts in vaccine research and policy.
Among the topics for discussion will be the role of vaccines in cancer prevention, as the EU prepares for a major cancer conference at the end of January. Vaccines that prevent cervical cancer and reduce the risk of liver cancer will contribute to addressing the overall burden of the disease in Europe and beyond.
At the same time, the importance of routine immunisation for people at all ages and stages of life has been highlighted by new measles outbreaks in Romania and globally. These preventable illnesses and deaths remain a key issue for public health.
And, with more than 100 vaccines in development for a wide range of diseases, we’ll look at how advances in technology and innovative tools could shape the future in which antimicrobial resistance (AMR) and climate change will be hot topics.
Sign up now and follow the discussion live. If you want a taste of the discussion at our last webinar, check out the video below. We cover tailored approaches to vaccination, life-course immunisation, the role of two-way communication and social media, and lots more.
